Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study

American Journal of Human Genetics

Volumn 82, Issue 5, 2008, Pages 1185-1192

  Ridker, Paul M ^a   Pare, Guillaume ^a   Parker, Alex ^b   Zee, Robert Y L ^a   Danik, Jacqueline S ^a   Buring, Julie E ^a   Kwiatkowski, David ^a   Cook, Nancy R ^a   Miletich, Joseph P ^b   Chasman, Daniel I ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

APOLIPOPROTEIN E GENE; ARTICLE; BODY WEIGHT; C REACTIVE PROTEIN GENE; CHROMOSOME POSITIONING; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOKINASE REGULATORY PROTEIN GENE; HEPATIC TRANSCRIPTOR FACTOR GENE; HOMEOSTASIS; HUMAN; HUMAN GENOME; INSULIN RESISTANCE; INTERLEUKIN 6 RECEPTOR PROTEIN GENE; LEPTIN RECEPTOR GENE; MATURITY ONSET DIABETES MELLITUS; METABOLIC SYNDROME X; NORMAL HUMAN; PANCREAS FUNCTION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOSIS;

C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FEMALE; GENOME, HUMAN; HUMANS; INFLAMMATION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MYOCARDIAL INFARCTION; PLASMA; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE;

EID: 42749092252     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2008.03.015     Document Type: Article

References (33)

1. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 336 (1997) 973-979
2. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., and Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
3. Laaksonen D.E., Niskanen L., Nyyssonen K., Punnonen K., Tuomainen T.P., Valkonen V.P., Salonen R., and Salonen J.T. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47 (2004) 1403-1410
4. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 347 (2002) 1557-1565
5. Han T.S., Sattar N., Williams K., Gonzalez-Villalpando C., Lean M.E., and Haffner S.M. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25 (2002) 2016-2021
6. Hage F.G., and Szalai A.J. C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. J. Am. Coll. Cardiol. 50 (2007) 1115-1122
7. Kathiresan S., Larson M.G., Vasan R.S., Guo C.Y., Gona P., Keaney Jr. J.F., Wilson P.W., Newton-Cheh C., Musone S.L., Camargo A.L., et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 113 (2006) 1415-1423
8. Crawford D.C., Sanders C.L., Qin X., Smith J.D., Shephard C., Wong M., Witrak L., Rieder M.J., and Nickerson D.A. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 114 (2006) 2458-2465
9. Carlson C.S., Aldred S.F., Lee P.K., Tracy R.P., Schwartz S.M., Rieder M., Liu K., Williams O.D., Iribarren C., Lewis E.C., et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am. J. Hum. Genet. 77 (2005) 64-77
10. Miller D.T., Zee R.Y., Suk Danik J., Kozlowski P., Chasman D.I., Lazarus R., Cook N.R., Ridker P.M., and Kwiatkowski D.J. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann. Hum. Genet. 69 (2005) 623-638
11. Ridker P.M., Chasman D.I., Zee R.Y., Parker A., Rose L., Cook N.R., Buring J.E., and for the Women's Genome Health Study Working Group. Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25000 initially healthy American women. Clin. Chem. 54 (2008) 249-255
12. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81 (2007) 559-575
13. Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, Saxena R., Voight B.F., Lyssenko V., Burtt N.P., de Bakker P.I., Chen H., Roix J.J., Kathiresan S., Hirschhorn J.N., Daly M.J., et al. Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316 (2007) 1331-1336
14. Sparso T., Anderson G., Nielsen T., Burgdorf K.S., Gjesing A.P., Nielsen A.L., Albrechtsen A., Rasmussen S.S., Jorgensen T., Borch-Johnsen K., et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 51 (2008) 70-75
15. Fajans S.S., Bell G.I., and Polonsky K.S. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N. Engl. J. Med. 345 (2001) 971-980
16. Garcia-Herrero C.M., Galan M., Vincent O., Flandez B., Gargallo M., Delgado-Alvarez E., Blazquez E., and Navas M.A. Functional analysis of human glucokinase gene mutations causing MODY2: exploring the regulatory mechanisms of glucokinase activity. Diabetologia 50 (2007) 325-333
17. Toniatti C., Demartis A., Monaci P., Nicosia A., and Ciliberto G. Synergistic trans-activation of the human C-reactive protein promoter by transcription factor HNF-1 binding at two distinct sites. EMBO J. 9 (1990) 4467-4475
18. Zhang Y.Y., Gottardo L., Mlynarski W., Frazier W., Nolan D., Duffy J., Marescotti M.C., Gervino E.V., Johnstone M.T., Mantzoros C.S., et al. Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels. Atherosclerosis 191 (2007) 121-127
19. Wallace A.M., McMahon A.D., Packard C.J., Kelly A., Shepherd J., Gaw A., and Sattar N. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104 (2001) 3052-3056
20. Chen K., Li F., Li J., Cai H., Strom S., Bisello A., Kelley D.E., Friedman-Einat M., Skibinski G.A., McCrory M.A., et al. Induction of leptin resistance through direct interaction of C-reactive protein with leptin. Nat. Med. 12 (2006) 425-432
21. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000) 836-843
22. Kado S., Nagase T., and Nagato N. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus. Acta Diabetol. 36 (1999) 67-72
23. Reich D., Patterson N., Ramesh V., De Jager P.L., McDonald G.J., Tandon A., Choy E., Hu D., Tamraz B., Pawlikowska L., et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am. J. Hum. Genet. 80 (2007) 716-726
24. Judson R., Brain C., Dain B., Windemuth A., Ruano G., and Reed C. New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. Atherosclerosis 177 (2004) 345-351
25. Austin M.A., Zhang C., Humphries S.E., Chandler W.L., Talmud P.J., Edwards K.L., Leonetti D.L., McNeely M.J., and Fujimoto W.Y. Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann. Hum. Genet. 68 (2004) 179-188
26. Chasman D.I., Kozlowski P., Zee R.Y., Kwiatkowski D.J., and Ridker P.M. Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein. Genes Immun. 7 (2006) 211-219
27. Bennet A.M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., Keavney B., Collins R., Wiman B., de Faire U., and Danesh J. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 298 (2007) 1300-1311
28. van den Elzen P., Garg S., Leon L., Brigl M., Leadbetter E.A., Gumperz J.E., Dascher C.C., Cheng T.Y., Sacks F.M., Illarionov P.A., et al. Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437 (2005) 906-910
29. Sima A., Iordan A., and Stancu C. Apolipoprotein E polymorphism-a risk factor for metabolic syndrome. Clin. Chem. Lab. Med. 45 (2007) 1149-1153
30. Lange L.A., Carlson C.S., Hindorff L.A., Lange E.M., Walston J., Durda J.P., Cushman M., Bis J.C., Zeng D., Lin D., et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296 (2006) 2703-2711
31. Pepys M.B., Hirschfield G.M., Tennent G.A., Gallimore J.R., Kahan M.C., Bellotti V., Hawkins P.N., Myers R.M., Smith M.D., Polara A., et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 440 (2006) 1217-1221
32. McVean G.A., Myers S.R., Hunt S., Deloukas P., Bentley D.R., and Donnelly P. The fine-scale structure of recombination rate variation in the human genome. Science 304 (2004) 581-584
33. Winckler W., Myers S.R., Richter D.J., Onofrio R.C., McDonald G.J., Bontrop R.E., McVean G.A., Gabriel S.B., Reich D., Donnelly P., et al. Comparison of fine-scale recombination rates in humans and chimpanzees. Science 308 (2005) 107-111